E71.440
Ruvalcaba-Myhre-Smith syndrome
Clinical Classification Guidelines
Medical Intelligence & Overview
Ruvalcaba-Myhre-Smith syndrome is a rare genetic disorder characterized by a combination of features affecting the skin, bones, and other body systems. Also known as a metabolic condition, it impacts how the body processes certain substances, leading to various clinical signs. Due to its rarity, understanding this syndrome is crucial for early diagnosis and management, which can improve the quality of life for affected individuals.
Causes & Symptoms
Clinical Causes: Mutations in specific genes involved in metabolic pathways Inheritance pattern: typically autosomal recessive, meaning both parents must pass on the mutated gene Genetic variations that disrupt normal enzyme functions
Key Symptoms: Skin abnormalities, including thickening and nodules Growth delays or short stature Bone deformities such as abnormal skull shape or joint issues Facial feature irregularities Potential neurological issues Other systemic effects depending on severity
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical examination and laboratory tests. Doctors may perform genetic testing to identify mutations associated with Ruvalcaba-Myhre-Smith syndrome. Imaging studies, such as X-rays, can help in assessing bone abnormalities, while blood tests might reveal biochemical disturbances related to the metabolic disorder.
Treatment Protocols: There is no specific cure for Ruvalcaba-Myhre-Smith syndrome. Treatment focuses on managing symptoms and preventing complications. This may include:
Clinical Advice & FAQs
Billing Guidance
Is E71.440 a billable ICD-10 code?
Yes, E71.440 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E71.440?
Clinical documentation must specify the nature of Ruvalcaba-Myhre-Smith syndrome and any associated comorbidities for accurate reporting.
Cite this Clinical Reference